Skip to main content
. 2014 Mar 25;98(7):926–931. doi: 10.1136/bjophthalmol-2013-304064

Figure 3.

Figure 3

Treatment differences (bimatoprost/timolol PF−bimatoprost/timolol) at each time point in average eye IOP (intent-to-treat population). Missing values were imputed using the last observation carried forward method. IOP, intraocular pressure; PF, preservative-free.